Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-25 @ 2:04 PM
NCT ID:
NCT05663866
Group ID:
EG002
Title:
Cohort B: Montelukast 10 mg
Description:
Participants were administered with oral montelukast 10 mg tablet as a prophylactic treatment once daily in the morning on Days - 4, -3, -2, -1, and Cycle 1 Day 1 prior to combination therapy of lazertinib 240 mg oral tablets and IV infusion of amivantamab 1050 mg (for participants \<80 kg) or 1400 mg (for participants \>=80 kg) on Cycle 1 Day 1 until disease progression or withdrawal from study. Each cycle was of 28 days.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
15
Other Number Affected:
15
Other Number At Risk:
15
Study:
NCT05663866
Results Section:
NCT05663866
Adverse Events Module:
NCT05663866